The Epoch TimesAspirin Inhibits Metastatic Cancer Spread, Reducing Mortality by 21 Percent: Study

Aspirin’s Emerging Role in Cancer Therapy: Beyond Pain Relief to Life-Saving Potential

Aspirin, a medication long established for its analgesic, anti-inflammatory, and anticoagulant properties, is now gaining attention in the oncology community. Recent comprehensive studies shed light on its potential to significantly reduce cancer mortality and prevent metastatic spread. Although its traditional use in pain and cardiovascular conditions is well-known, aspirin’s emerging role in cancer treatment is a promising development, offering a new dimension to its clinical applications.

Key Points:

1. Reduction in Cancer Mortality: Recent studies show that daily intake of low-dose aspirin (75-81 milligrams) is linked to a 21% reduction in all-cause mortality in cancer patients, marking a significant step in cancer treatment.
2. Effect on Pancreatic Cancer Survival: Pancreatic cancer patients taking aspirin post-surgery exhibited a three-year survival rate of 61.1%, significantly higher than the 26.3% for non-users.
3. Inhibition of Metastatic Cancer Spread: Aspirin’s role in inhibiting platelet aggregation is crucial in reducing metastasis, with studies indicating a 38-52% lower risk of cancer spread.
4. Mechanism of Action: Aspirin’s anti-cancer effects stem from COX enzyme inhibition, impacting cancer cell proliferation, inflammation, and platelet activity.
5. Promotion of DNA Repair: Aspirin enhances DNA repair mechanisms, crucial in preventing cancers like hereditary non-polyposis colorectal cancer.
6. Controversy and Bleeding Risks: Despite its benefits, aspirin’s use in cancer is controversial due to increased bleeding risks, particularly in elderly patients.
7. Evidence of Safety: Data from randomized trials suggests that bleeding caused by aspirin is generally mild, with a lower death rate compared to control groups.
8. Preventative Measures for Various Cancers: Aspirin use is associated with a reduced risk of several cancers, including colorectal, esophageal, stomach, and hepatobiliary tract cancers.
9. Potential Risks and Precautions: Long-term aspirin use requires caution, especially in children, patients with allergies, ulcers, or certain chronic conditions.
10. Broader Implications: The findings suggest aspirin’s role as a preventative and therapeutic agent in cancer, advocating for more randomized trials to explore its full potential.

According to a study by the National Cancer Institute, regular aspirin use may lower the risk of ovarian cancer by 20%.

More on Aspirin